drugset / Trial / NCT07634393

Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment

NCT07634393

Phase 4 Not yet recruiting 200 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The IMPACT study is a randomized, double-blind clinical trial evaluating two commonly used intravenous medications - metoclopramide and acetaminophen - for treating acute post-concussion symptoms in emergency department patients after mild head injury. The study aims to determine which treatment more effectively improves symptoms such as headache, dizziness, nausea, concentration difficulties, and emotional changes within the first week after injury. Participants will be enrolled across two Montefiore emergency departments and followed using a validated post-concussion symptom questionnaire. Findings from this study may help improve evidence-based treatment strategies for patients experiencing concussion-related symptoms after head trauma.

Timeline

Start
2026-08-01
Primary completion
2028-06-30
Completion
2028-08-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Intravenous
Comparator Metoclopramide Small molecule 10 mg Intravenous